BRILINTA

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Hong Kong, Israel, Japan, Mexico, New Zealand, Singapore, Turkey, United States, South Africa

Active ingredients

The drug BRILINTA contains one active pharmaceutical ingredient (API):

1 Ticagrelor UNII GLH0314RVC - TICAGRELOR

Ticagrelor is an oral, direct acting, selective and reversibly binding P2Y12 receptor antagonist that prevents ADP-mediated P2Y12 dependent platelet activation and aggregation. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function has been shown to reduce the risk of CV events such as death, MI or stroke. Read about Ticagrelor

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BRILINTA Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC24	Ticagrelor	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1418P
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502306401116211, 502306402112218, 502306403119216, 502320120034207, 502320120034307
Country: CA	Health Products and Food Branch	Identifier(s): 02368544, 02455005
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 3200-MEE-0418, 363031112
Country: HK	Department of Health Drug Office	Identifier(s): 61187, 64706
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6678, 7933
Country: JP	医薬品医療機器総合機構	Identifier(s): 3399011F1027, 3399011F2023
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 216M2011
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14940, 17895
Country: SG	Health Sciences Authority	Identifier(s): 14120P, 15294P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786090286, 8699786090293, 8699786092785
Country: US	FDA, National Drug Code	Identifier(s): 0186-0776, 0186-0777, 55154-9618
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/8.2/1041